| 31st week of 2021 patent applcation highlights part 26 |
| Patent application number | Title | Published |
|---|
| 20210238114 | Method For Producing Catalysts Having Increased Strength And Decreased Volume Reduction | 2021-08-05 |
| 20210238115 | METHOD FOR MANUFACTURING ISOPULEGOL | 2021-08-05 |
| 20210238116 | Mixture for Use as a Liquid Sorption Agent in Methanol Synthesis and Methanol Synthesis Process Using Said Mixture | 2021-08-05 |
| 20210238117 | PROCESSES FOR SOLVENT EXTRACTION OF CANNABINOIDS, TERPENES AND FLAVONOIDS FROM BIOMASS | 2021-08-05 |
| 20210238118 | METHOD FOR PRODUCING ACETYLACETONATE FROM A HYDRATED OR ANHYDROUS CHEMICAL ELEMENT | 2021-08-05 |
| 20210238119 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | 2021-08-05 |
| 20210238120 | 3-AMINO-4-HALOCYCLOPENTENE CARBOXYLIC ACIDS AS INACTIVATORS OF AMINOTRANSFERASES | 2021-08-05 |
| 20210238121 | METHOD FOR PREPARING BENZYL AMINE COMPOUND | 2021-08-05 |
| 20210238122 | IGM COMPOSITIONS AND METHODS OF MUCOSAL DELIVERY OF THESE COMPOSITIONS | 2021-08-05 |
| 20210238123 | METHOD OF PRODUCING N,N-DISUBSTITUTED AMIDE AND CATALYST FOR PRODUCING N,N-DISUBSTITUTED AMIDE | 2021-08-05 |
| 20210238124 | ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER | 2021-08-05 |
| 20210238125 | Diabetes and Metabolic Syndrome Treatment with a Novel Dual Modulator of Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptors | 2021-08-05 |
| 20210238126 | Benzamide Compound and Use Thereof | 2021-08-05 |
| 20210238127 | FTO Inhibitors | 2021-08-05 |
| 20210238128 | COMPOUNDS CONTAINING CYCLIC STRUCTURAL ELEMENTS, URETHANE/UREIDO LINKAGES AND A FREE RADICAL-POLYMERIZABLE FUNCTIONAL GROUP | 2021-08-05 |
| 20210238129 | SELECTIVE POTASSIUM CHANNEL AGONISTS | 2021-08-05 |
| 20210238130 | COMPOUNDS FOR THE MODULATION OF CYCLOPHILINS FUNCTION | 2021-08-05 |
| 20210238131 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | 2021-08-05 |
| 20210238132 | IONIC LIQUID ELECTROLYTE | 2021-08-05 |
| 20210238133 | CYCLOPROPANATION METHOD | 2021-08-05 |
| 20210238134 | ALKYLAMINE-SUBSTITUTED PERTHIOCARBAMATES AS DUAL PRECURSORS TO HYDROPERSULFIDE AND CARBONYL SULFIDE | 2021-08-05 |
| 20210238135 | GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF | 2021-08-05 |
| 20210238136 | AZETIDINE DERIVATIVE, AND PRODRUG THEREOF | 2021-08-05 |
| 20210238137 | METHOD AND APPARATUS FOR RECOVERING AMIDE-BASED COMPOUND | 2021-08-05 |
| 20210238138 | Method for improving nucleation of crystals from solution | 2021-08-05 |
| 20210238139 | MODULATORS OF TRYPTOPHAN CATABOLISM | 2021-08-05 |
| 20210238140 | Compounds for Targeting Cancer Stem Cells | 2021-08-05 |
| 20210238141 | COMPOUND, CURING AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | 2021-08-05 |
| 20210238142 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | 2021-08-05 |
| 20210238143 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING CD95-MEDIATED CELL MOTILITY | 2021-08-05 |
| 20210238144 | Phenyl Derivatives | 2021-08-05 |
| 20210238145 | DIARYLHYDANTOIN COMPOUNDS | 2021-08-05 |
| 20210238146 | ONE POT SYNTHESIS OF 4-(1,2-DIHYDRO-2-OXOBENZO[D]IMIDAZOL-3-YL)BUTANOIC ACID, A KEY INTERMEDIATE OF ZILPATEROL | 2021-08-05 |
| 20210238147 | 5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS | 2021-08-05 |
| 20210238148 | PYRIMIDINE CYCLOHEXENYL GLUCOCORTICOID RECEPTOR MODULATORS | 2021-08-05 |
| 20210238149 | PROCESS FOR THE PRODUCTION OF TETRAAMINOBIPHENOL MACROCYCLIC LIGANDS; AND NOVEL TETRAAMINOBIPHENOL MACROCYCLIC LIGANDS | 2021-08-05 |
| 20210238150 | PRODUCTION METHOD FOR 5,5-DI-SUBSTITUTED-4,5-DIHYDROISOXAZOLE | 2021-08-05 |
| 20210238151 | OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES | 2021-08-05 |
| 20210238152 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS | 2021-08-05 |
| 20210238153 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | 2021-08-05 |
| 20210238154 | OXADIAZOLE COMPOUNDS | 2021-08-05 |
| 20210238155 | CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS | 2021-08-05 |
| 20210238156 | PHOTOCHROMIC COMPOUNDS FOR USE IN THE TREATMENT OF EYE DISORDERS | 2021-08-05 |
| 20210238157 | Novel Cannabinoids and Cannabinoid Acids and Their Derivatives | 2021-08-05 |
| 20210238158 | PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2021-08-05 |
| 20210238159 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use | 2021-08-05 |
| 20210238160 | AMORPHOUS FORM OF TETRACYCLIC COMPOUND | 2021-08-05 |
| 20210238161 | HISTONE DEMETHYLASE INHIBITORS | 2021-08-05 |
| 20210238162 | CHEMICAL COMPOUNDS | 2021-08-05 |
| 20210238163 | CRYSTAL FORM OF C-MET INHIBITOR AND SALT FORM THEREOF AND PREPARATION METHOD THEREFOR | 2021-08-05 |
| 20210238164 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | 2021-08-05 |
| 20210238165 | HETEROARYL RHEB INHIBITORS AND USES THEREOF | 2021-08-05 |
| 20210238166 | DEUTERATED DEFACTINIB COMPOUND AND USE THEREOF | 2021-08-05 |
| 20210238167 | SMALL MOLECULE IRE1-ALPHA INHIBITORS | 2021-08-05 |
| 20210238168 | BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS | 2021-08-05 |
| 20210238169 | PROCESS FOR PREPARING A COMPOUND OF FORMULA (XIII) | 2021-08-05 |
| 20210238170 | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators | 2021-08-05 |
| 20210238171 | BENZISOXAZOLE COMPOUND | 2021-08-05 |
| 20210238172 | HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS AND METHODS OF USING THE SAME | 2021-08-05 |
| 20210238173 | MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS | 2021-08-05 |
| 20210238174 | DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA | 2021-08-05 |
| 20210238175 | SOLID STATE FORMS OF VENETOCLAX AND PROCESSES FOR PREPARATION OF VENETOCLAX | 2021-08-05 |
| 20210238176 | PESTICIDALLY-ACTIVE BICYCLIC HETEROAROMATIC COMPOUNDS | 2021-08-05 |
| 20210238177 | CRYSTALLINE FORMS OF 3-((1R,5S,9r)-9-ETHOXY-3-AZABICYCLO[3.3.1]NONAN-9-YL)-BENZAMIDE AND SALT FORMS THEREOF | 2021-08-05 |
| 20210238178 | INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF LINAGLIPTIN AND ITS SALTS | 2021-08-05 |
| 20210238179 | HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS | 2021-08-05 |
| 20210238180 | THE CRYSTALLINE FORMS OF A COMPOUND | 2021-08-05 |
| 20210238181 | IMIDAZOPYRIDINES USEFUL AS MITOCHONDRIAL UNCOUPLERS | 2021-08-05 |
| 20210238182 | IMIDAZOPYRAZINONES AS PDE1 INHIBITORS | 2021-08-05 |
| 20210238183 | SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS | 2021-08-05 |
| 20210238184 | THERAPEUTIC COMPOUNDS | 2021-08-05 |
| 20210238185 | CRYSTAL FORMS OF AN ALK2 INHIBITOR | 2021-08-05 |
| 20210238186 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | 2021-08-05 |
| 20210238187 | AZIRIDINE CONTAINING EPOTHILONE ANALOGS, METHODS OF SYNTHESIS, METHODS OF TREATMENT, AND DRUG CONJUGATES | 2021-08-05 |
| 20210238188 | HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS | 2021-08-05 |
| 20210238189 | NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | 2021-08-05 |
| 20210238190 | THIENO[2,3-C]PYRIDAZIN-4(1H)-ONE DERIVATIVE AND APPLICATION THEREOF | 2021-08-05 |
| 20210238191 | CRYSTAL FORMS OF THIOPHENE DERIVATIVES | 2021-08-05 |
| 20210238192 | VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF | 2021-08-05 |
| 20210238193 | PROTEIN DEGRADERS AND USES THEREOF | 2021-08-05 |
| 20210238194 | TETRAHYDROPYRANOOXAZINE DERIVATIVES HAVING SELECTIVE BACE1 INHIBITORY ACTIVITY | 2021-08-05 |
| 20210238195 | CRYSTALLINE POLYMORPHS OF A MUSCARINIC ACETYLCHOLINE RECEPTOR AGONIST | 2021-08-05 |
| 20210238196 | SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF | 2021-08-05 |
| 20210238197 | NOVEL OXOQUINOLIZINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2021-08-05 |
| 20210238198 | TYK2 INHIBITORS AND USES THEREOF | 2021-08-05 |
| 20210238199 | SILVER-CARBON COMPOSITE, METHOD FOR MANUFACTURING THE SAME AND ANTIBACTERIAL LIQUID | 2021-08-05 |
| 20210238200 | CHIRAL N-SUBSTITUTED ALLYLIC AMINE COMPOUNDS | 2021-08-05 |
| 20210238201 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | 2021-08-05 |
| 20210238202 | NOVEL ORGANOBORANES USEFUL AS ELECTROLYTES FOR LITHIUM BATTERIES | 2021-08-05 |
| 20210238203 | COMPOSITION, PHOTOELECTRIC CONVERSION ELEMENT, AND IMAGING DEVICE | 2021-08-05 |
| 20210238204 | INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF | 2021-08-05 |
| 20210238205 | ROTAXANE COMPOUND | 2021-08-05 |
| 20210238206 | PRODUCTION METHOD FOR ORGANIC SILICON COMPOUND HAVING KETIMINE STRUCTURE | 2021-08-05 |
| 20210238207 | COMPOSITIONS AND METHODS RELATING TO MOLECULAR CERIUM-OXIDE NANOCLUSTERS | 2021-08-05 |
| 20210238208 | Novel Plasmalogen Derivatives | 2021-08-05 |
| 20210238209 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | 2021-08-05 |
| 20210238210 | ANTIVIRAL COMPOUNDS | 2021-08-05 |
| 20210238211 | NEAR-IR ACTIVATABLE FLUORESCENT SMALL MOLECULES WITH DUAL MODES OF CYTOTOXICITY | 2021-08-05 |
| 20210238212 | METAL-LIGAND CATALYSTS FOR SELECTIVE PROMOTION OF ELECTROCHEMICAL CO2RR | 2021-08-05 |
| 20210238213 | SOLID-PHASE SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING N6-(2-DEOXY-ALPHA,BETA-DERYTHROPENTOFURANOSYL)-2,6-DIAMINO-4-HYDROXY-5-FO- RMAMIDOPYRIMIDINE (Fapy.dG) | 2021-08-05 |
